APA Alıntı

Go, S., Ko, G. H., Lee, W. S., Lee, J., Jeong, S., Lee, Y., . . . Ha, W. S. (2019). The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer. Cancer Res Treat.

Chicago Stili Alıntı

Go, Se-Il, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, ve Woo Song Ha. "The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer." Cancer Res Treat 2019.

MLA Alıntı

Go, Se-Il, et al. "The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer." Cancer Res Treat 2019.